These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 17599818)
1. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas. Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818 [TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613 [TBL] [Abstract][Full Text] [Related]
3. Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma. Ben Nasr H; Chahed K; Mestiri S; Bouaouina N; Snoussi K; Chouchane L Hum Immunol; 2007 Sep; 68(9):761-9. PubMed ID: 17869651 [TBL] [Abstract][Full Text] [Related]
4. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma. Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295 [TBL] [Abstract][Full Text] [Related]
5. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Zhu Y; Spitz MR; Lei L; Mills GB; Wu X Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799 [TBL] [Abstract][Full Text] [Related]
6. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis]. Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315 [TBL] [Abstract][Full Text] [Related]
7. Functional vascular endothelial growth factor -2578 C/A polymorphism in relation to nasopharyngeal carcinoma risk and tumor progression. Nasr HB; Chahed K; Bouaouina N; Chouchane L Clin Chim Acta; 2008 Sep; 395(1-2):124-9. PubMed ID: 18588866 [TBL] [Abstract][Full Text] [Related]
8. Genetic variations in the matrix metalloproteinase-1 promoter and risk of susceptibility and/or severity of chronic periodontitis in the Czech population. Hollá LI; Jurajda M; Fassmann A; Dvorakova N; Znojil V; Vacha J J Clin Periodontol; 2004 Aug; 31(8):685-90. PubMed ID: 15257748 [TBL] [Abstract][Full Text] [Related]
9. The association of MMP-1, -3 and -9 genotypes with the prognosis of HCV-related hepatocellular carcinoma patients. Okamoto K; Mandai M; Mimura K; Murawaki Y; Yuasa I Res Commun Mol Pathol Pharmacol; 2005; 117-118():77-89. PubMed ID: 18426080 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population. Takemura N; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593 [TBL] [Abstract][Full Text] [Related]
11. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility. Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285 [TBL] [Abstract][Full Text] [Related]
12. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma. Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population. Astolfi CM; Shinohara AL; da Silva RA; Santos MC; Line SR; de Souza AP J Clin Periodontol; 2006 Oct; 33(10):699-703. PubMed ID: 16899023 [TBL] [Abstract][Full Text] [Related]
14. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma. Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721 [TBL] [Abstract][Full Text] [Related]
15. [Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer]. Li Y; Wang Y; Kang S; Zhang JH; Guo W; Wang N; Jin X; Fang SM Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):472-5. PubMed ID: 16080875 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk. Su L; Zhou W; Park S; Wain JC; Lynch TJ; Liu G; Christiani DC Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):567-70. PubMed ID: 15767330 [TBL] [Abstract][Full Text] [Related]
18. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Ghilardi G; Biondi ML; Caputo M; Leviti S; DeMonti M; Guagnellini E; Scorza R Clin Cancer Res; 2002 Dec; 8(12):3820-3. PubMed ID: 12473595 [TBL] [Abstract][Full Text] [Related]
19. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users. Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834 [TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]